<DOC>
	<DOCNO>NCT01506726</DOCNO>
	<brief_summary>The purpose study determine whether treatment unexplained anemia old adult elevate inflammatory marker oral salsalate improve hemoglobin level improve physical activity quality life .</brief_summary>
	<brief_title>Trial To Evaluate Efficacy Oral Salsalate Treatment Older Adults With Unexplained Anemia</brief_title>
	<detailed_description>There well-defined morbidity mortality associate anemia elderly increase proportion elderly adults underscore population 's attributable risk anemia . As potentially modifiable factor , urgent need exists delineate impact anemia correction elderly . The Partnership Anemia : Clinical Translational Trials Elderly ( PACTTE ) consortium create focus treatment strategy anemia elderly patient . The data present protocol provide compelling rationale evaluate impact anti-inflammatory ( Salsalate ) old anemic adult elevate serum iL-6 level . Subjects 65 year old adult unexplained anemia elevate serum iL-6 ≥ 1.0 pg/mL . Subjects receive 750mg salsalate matching placebo ( one pill ) twice day ( pm ) one month . After one month dose increase 1500mg ( 2 pill ) twice day ( pm ) 750mg dose tolerate 5 month ( total 6 month ) The primary endpoint ass whether salsalate improves hemoglobin level baseline 6 month visit .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>Understand voluntarily sign informed consent form Age 65 year old , reside community assistedliving facility Able adhere study visit schedule protocol requirement Hemoglobin concentration ≥ 9.0 g/dL &lt; 11.5 g/dL woman ≥ 9.0 &lt; 12.7 g/dL men Unexplained anemia ( See Appendix 2 definition anemia diagnosis determine anemia unexplained ) Serum IL6 level ≥ 1.0 pg/mL obtain screening period ( performed central laboratory ) . Must able understand speak English ; Spanish speaking subject speak English may enrol per local IRB process approval , provide site appropriate bilingual study staff . Red blood cell transfusion within past 3 month Estimated glomerular filtration rate ( eGFR ) &lt; 30 ml/min ( abbreviated MDRD ) Use erythropoiesis stimulate agent ( ESA ) past 3 month Active infection define symptomatic , require active treatment ( prophylaxis allow ) hospitalize &gt; 24 hour primarily infection within past month Uncontrolled hypertension define diastolic blood pressure &gt; 95 mm Hg systolic blood pressure &gt; 160 mm Hg 2 separate occasion screen period Distance 6MWT median age sex adjust population median ( see Table 4 ) Other primary uncorrected cause anemia include : Known active inflammatory disease include autoimmune disease ( e.g. , systemic lupus erythematosis , rheumatoid arthritis , mixed connective tissue disease , sarcoidosis , bronchiolitis obliterans , vasculitis , polymyalgia rheumatica , temporal arteritis , inflammatory bowel disease related disease ) ; Chronic active infection ( e.g. , HIV , viral hepatitis , tuberculosis , osteomyelitis ) receive therapy within past 3 month chronic infection Acute infection within past 3 month ( pneumonia , sepsis , bacteremia , prostatitis , urosepsis , pyelonephritis , cholecystitis ) Receipt immunosuppressive therapy past 2 year include prednisone except topical therapy Any cancer ( aside nonmelanoma skin cancer ) past 2 year therapy cancer . In addition , prostate cancer exclude patient metastatic disease , prostatectomy within prior 6 month , ever receive external beam radiation therapy brachytherapy , receive androgen deprivation therapy prior 24 month . Subjects history form cancer likewise exclude receive radiation chemotherapy prior 24 month . Fecal Occult Blood Test positivity past 3 year , Gastrointestinal bleeding past 3 year history peptic ulcer w/ evidence bleeding Elevated AST ALT ≥ 2x upper limit normal Use experimental drug therapy within 28 day initial screening visit History moderate tinnitus affect instrumental activity daily activity past 3 month Current use acetylsalicylic acid ( aspirin ) dose great 82 mg/day past 3 month . Subjects also ineligible consume expect consume nonsteroidal antiinflammatory drug ( NSAIDs ) , corticosteroid , methotrexate , furosemide anticoagulant course study . Elevated thyroid stimulate hormone ( TSH ) , sign hypothyroid condition . Patients stable dose thyroid replacement eligible , provide TSH elevate . Seizure disorder phenytoin use treatment . Hypersensitivity salsalate , salicylic acid , acetylsalicylic acid History transient ischemic attack ( TIA ) , cerebral vascular accident , clinical diagnosis angina myocardial infarction , coronary intervention ( PCI , Bypass , Stent placement ) within prior 12 month reduce risk subject require aspirin therapy trial Dementia define inability independently provide informed consent Montreal Cognitive Assessment ( MoCA ) score &lt; 22</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>anemia</keyword>
	<keyword>unexplained anemia</keyword>
	<keyword>elderly</keyword>
	<keyword>geriatric</keyword>
	<keyword>old adult</keyword>
	<keyword>UAE</keyword>
	<keyword>65</keyword>
	<keyword>salsalate</keyword>
	<keyword>PACTTE</keyword>
	<keyword>pactee</keyword>
	<keyword>age</keyword>
	<keyword>age</keyword>
	<keyword>old</keyword>
	<keyword>old</keyword>
</DOC>